Several human diseases have been found to be caused by mitochondrial DNA (mtDNA) mutations. Pathogenic mutated (mut) mtDNAs are usually "heteroplasmic," coexisting intracellularly with wild-type (wt) mtDNAs. For some mtDNA mutations, cells have normal levels of respiratory chain function unless the percentage of mut-mtDNA is very high. Although progress in understanding the molecular basis of mitochondrial diseases has been remarkable, the heterogeneity of mut-mtDNA distribution, even among cells of the same tissue, makes it difficult to clearly delineate the relationships between mtDNA mutations, gene dosage, and clinical phenotypes. In a search for screening methods for idennfying cultured cells with deficient mitochondrial function, we incubated living cells harboring mut-mtDNAs with dihydrorhodamine 123 (DHR123), an uncharged, noduorescent agent that can be converted by oxidation to the fluorescent laser dye rhodamine 123 (R123). Bright mitochondrial staining was observed in cells that respired normally. Fluorescence was significantly reduced in cells with mitochondrial respiratory chain dysfunction resulting from very high levels of mut-mtDNAs. The data show that DHR123 is useful for assessing mitochondrial function in single cells, and can be used for isolating viable, respiratory chain-deficient cells from heterogeneous cultures. ( J Hisrochem Cyrochem 44: 571-579, 19%) 
Introduction
Mitochondria are cellular organelles that contain their own DNA, which is maternally inherited (Giles et al., 1980) . Each mitochondrion contains approximately two to ten circular genomes, encoding two ribosomal RNAs, 22 transfer RNAs, and 13 polypeptides that are components of the respiratory chain (Anderson et al., 1981) . The mtDNA acts in concert with the nuclear genome. The mtDNAencoded polypeptides are assembled in the mitochondria, together with nuclear DNA-encoded polypeptides that are synthesized in the cytoplasm and transported into the appropriate mitochondrial compartment (Attardi and Schatz, 1988) .
Mitochondrial encephalomyopathies are a clinically heterogeneous group of genetic disorders affecting mitochondrial metabolism. They are defined biochemically by deficiencies of respiratory chain enzymes or morphologically by muscle fibers containing large, irregular accumulations of mitochondria that stain bright red with a modified Gomori trichrome stain and hence were given the name "ragged-red fibers" (Engel and Cunningham, 1963) . Some mitochondrial diseases are caused by nuclear DNA mutations, and are inherited in a Mendelian fashion (Moraes et al., 1991; . However, a number of mitochondrial encephalomyopathies have been shown to be caused by large-scale mtDNA deletions or partial duplications, that are are usually nonfamilial (Moraes et al., 1989a; Poulton et al., 1989; Holt et al., 1988; Lestienne and Ponsot, 1988; Zeviani et al., 1988) or by point mutations that are maternally inherited (for review see Shdner and Wallace, 1994; Wallace, 1992) . Cells, tissues, and cell cultures from patients are usually heteroplasmic, containing both mut-mtDNAs and wt-mt-DNAs (see Shoffner and Wallace, 1994; and Wallace, 1992 for review; Shanske et al., 1990; Moraes et al., 1989a,b) . Cells and tissues often contain variable proportions of mut-mtDNA and wt-mtDNA, because each cell contains multiple copies of mtDNA, which during mitosis undergo replicative segregation (Wallace, 1986) . Although the genomic location of large-scale mtDNA rearrangements or point mutations can dlffer among patients and does not usually show a correlation with severity of the clinical symptoms, alterations in the percentage and tissue distribution of mut-mtDNAs usually appear to contribute to the manifestation of the disease. Several studies have shown that mitochondrial function in cells from patients is normal unless the relative proportion of mut-mtDNA vs wt-mtDNA within the cell reaches a certain threshold (Shoubridge, 1995; see Shoffner and Wallace, 1994 and Wallace, 1992 for review; Boulet et al., 1992; Chomyn et al., 1992; Sancho et al., 1992; Hayashi et al., 1991; Moraes et al., 1989b) . This threshold level may differ for different mutations and among tissues with different oxygen demands .
Molecular genetic studies aimed at clarifying the pathophysiology of mitochondrial encephalopathies associated with mtDNA mutations are often hampered by the uneven distribution of mut-mtDNAs in the patients' tissues or in cell cultures derived from them. To overcome this problem, modified cell culture techniques are being utilized that permit the isolation of long-lived or immortal cells containing more homogeneous, genetically defined mtDNA populations. One such culture model involves somatic cell hybridization of a strain of HeLa cells carrying selectable genetic markers with cells from patients with mtDNA mutations. In subsequent cell generations, clonal hybrids can be identified that contain varying ratios of mutated and wt-mtDNAs, in which the HeLa mtDNA, recognizable by polymorphisms that alter restriction endonuclease patterns, is sometimes selectively lost (Sancho et al., 1992; Shay and Ishii, 1990; Miranda et al., 1989) . In addition, a culture model has been described for vertebrate cells in which the native mtDNA is completely eliminated by long-term treatment with ethidium bromide (Desjardins et al., 1985) . Using this method, King and Attardi (1989) generated human cell lines that are totally devoid of mtDNA, containing selectable genetic markers. These Rhoo cells can be repopulated with exogenous mtDNA by fusion with enucleated cells (cytoplasts) derived from patients harboring mtDNA mutations. Analysis of clonal cybrids, homoplasmic for the mut-mtDNA or harboring well-defined wt-mtDNA to mut-mtDNA ratios have permitted an analysis of pathogenic mtDNA mutations against a neutral, nonpatient nuclear DNA background (Dunbar et al., 1995; Masucci et al., 1995; Shoubridge, 1995; Tiranti et al., 1995; Trounce et al., 1994; Chomyn et al., 1991 Chomyn et al., ,1992 King et al., 1992; Hayashi et al., 1991; Yoneda et al., 1990) . The cultures can be studied biochemically, cytochemically, or polarographically to determine the pathogenic consequences of mtDNA mutations. However, because such methods are usually destructive, replicate clonal cultures must be maintained for further propagation and analysis.
In this study we describe a simple and reliable qualitative microscopic technique that facilitates the identification and direct isolation of viable individual cells or cell clones with an impaired mitochondrial respiratory chain. The method was applied to cell cybrids and hybrids containing different pathogenic mtDNA mutations: cybrids harboring point mutations associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) (King et al., 1992; Goto et al., 1990) ; myoclonic epilepsy and ragged-red fibers (MERRF) (Masucci et al., 1995; Zeviani et al., 1993; Silvestri et al., 1992; Yoneda et al., 1990) ; and somatic cell hybrids harboring a large-scale mtDNA deletion derived from cells from a patient with Keams-Sayre syndrome (KSS) (Sancho et al., 1992; Moraes et al., 1989a,b; Holt et al., 1988; Zeviani et al., 1988) .
Materials and Methods
Staining and Microscopy. A stock solution of 10 mM DHR123 (Molecular Probes; Eugene, OR) prepared in 100% dimethyl sulfoxide was further diluted to 5, 10, or 20 BM in complete growth medium (see below). The cultures were incubated for 30,45, or 60 min at 37% in 5% CO2 and air with DHR123-containing growth medium at specified concentrations and were briefly rinsed three times with Earle's balanced salt solution (EBSS) at 37°C. The cells were immediately analyzed with a x 25 or x40 objective lens in a Zeiss microscope with epi-illumination. The excitation wave length was 485 nm. The cell preparations in each experiment were photographed at the same light intensity and time of exposure. For quantitative studies, the intensity of fluorescence was estimated with a Biorad Laser Sharp MRC-600 confocal attachment, equipped with a 25 mW argon laser and coupled to a Leitz Orthoplan microscope, operated according to instructions in the software manual. The cells were analyzed in a single-channel mode, using a x 100 oil-immersion objective lens and a filter block for fluorescein-labeled samples. The means and standard deviations were determined for at least five digitized microscopic images of cells within a previously defined rectangular area. For all quantitative analyses the nuclei were unstained, but for illustrative purposes the nuclei were sometimes visualized by staining for 60 min at 37°C with 8 pM Hoechst 33258 dye (Polysciences; Warring ton, PA) prepared in complete growth medium, and rinsed with EBSS at 37°C before incubation with DHR123.
Cell Culture. Cybrids were obtained by fusing human 143B206 (Rhoo) cells, depleted of their mtDNA by ethidium bromide treatment (King and Attardi, 1989) , with enucleated fibroblasts ot myoblasts (cytoplasts) of patients presenting with MELAS or MERRF. Several clonal cell lines possessing known levels of specific mtDNA mutations were utilized. These include cybrids harboring the MELAS3243 mutation, RN 204, which possesses 0% mut-mtDNA, and RN 164, which possesses >99% mut-mtDNA (King et al., 1992) . Also studied were cybrids harboring the mutation, LB 18 and LB 3, which possess 0 and 100% mut-mtDNA, respectively, and cybrids with the MJ2RRP3>' mutation, KB 30 and KB 57, which possess 0% and 100% mut-mtDNA, respectively (Masucci et al., 1995) .
Hybrids were obtained by fusion of HeLacot cells with fibroblasts of a patient with KSS harboring a 4977-BP deletion in mtDNA, the so-called "common deletion" (Schon et al., 1989) , as described previously (Sancho et al., 1992) . Clonal hybrid cultures harboring <5% (BH10.3) or >99% of mtDNAs (BH10.13) with deletions were analyzed (Sancho et al., 1992) . Uncloned cultures of HeLacot x KSS hybrids containing various proportions of wt-mtDNAs and deleted mtDNAs were also studied. They were plated at low (clonal) density (200-400 cells/dish) in 10-cm culture dishes to allow identification and isolation of discrete cell colonies. After 1 week the cultures were exposed to DHR123-containing medium. Colonies were scored microscopically for intensity of fluorescence, isolated with glass cloning rings as described (Miranda et al., 1986) , and propagated for 2-4 weeks for subsequent analysis.
The hybrids and cybtids were cultivated at saturation humidity in a 37°C incubator in 5 % CO2 and air. The growth medium consisted of complete Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum, containing 10 pg/ml gentamycin and 1 pg/ml amphotericin B (medium components from Gibco Labs, Life Technologies, Grand Island, NY). Because the cells with respiratory chain dysfunction require uridine for growth (King and Attardi, 1989; Desjardins et al., 1985) . the culture medium was also supplemented with 50 pg/ml uridine. The cultures were grown in 10cm culture dishes, or 3.5-cm cluster dishes (Falcon; Becton Dickinson, Lincoln Park, NJ) with 22-mm coverslip inserts.
Growth Curves. Parental 143B cells, from which the Rhoo cells were derived, were rinsed and trypsinized after incubation for 45 min at 37°C in DHR123-containing growth medium. The cells were counted in a hemocytometer, suspended in 10 ml culture medium, and plated in 10-cm Petri dishes at a density of 1 x lo1 cells per dish. The cells were trypsinized and counted at 24-hr intervals for 5 days.
DNA Analysis. To determine the percentage of mut-mtDNAs in selected KSS x HeLa hybrids, total DNA was extracted and analyzed by the Southern blot method (Sambrook and Maniatis, 1989) . Briefly, about 2pg of total DNA was digested with the restriction enzyme F'vu 11, electrophoresed through a 0.9% agarose gel, transferred to a nylon membrane (Zeta probe GT; Bio-Rad Labs, Melville, NY), and hybridized with total mtDNA obtained from human placenta. The probe was labeled with a-[32P]-dATP using the random primed labeling kit (Boehringer Mannheim; Indianapolis, IN). The ratios ofmut-mtDNAs and wt-mtDNAs were quantified in a Betascope 603 (Betagen; Waltham, MA). To assess the percentages of mut-mtDNAs in MERRF and MELAS cybrids, extracted total DNA was analyzed by the polymerase chain reaction (PCR), as described previously (Masucci et al., 1995; King et al., 1992) .
Oxygen Consumption. To assess the utilization of oxygen in selected cell cultures, 5 x lo6 cells, suspended in 1.65 ml DMEM without serum or glucose, were studied polarographically at 37'C, using an oxygen electrode as described previously (King et al., 1992) . Four measurements were performed for each sample.
Enzyme Cytochemistry. To evaluate cytochrome c oxidase (COX) activity, cells grown on coverslips were rinsed with PBS at 37°C and air-dried for 15 min, followed by a 4-hr incubation in diaminobenzidine and cytochrome c (Seligman et al., 1968) . Succinic acid dehydrogenase (SDH) activity was evaluated in air-dried preparations stained for 15 min (Seligman and Rutenberg, 1951) .
All studies reported here were performed after approval by the Institutional Review Board on Human Investigation of Columbia University.
Results

DHR 123 Analysis
We evaluated the utility of DHR123 conversion to R123 (Figure 1) for identifying impaired oxidative phosphorylation in cultured cybrids and hybrids derived from patients harboring pathogenic mtDNA mutations. Clonal cells, known to be respiration-deficient as determined by oxygen consumption, were compared with clonal cells showing normal rates of respiration ( Figure 2 ). Three distinct defects of mtDNA associated with three major mitochondrial encephalomyopathies were studied, utilizing two different cell culture systems: clonal cell cybrids obtained by fusing Rhoo cells with enucleated fibroblasts from patients harboring the MELAS3243, MERRF8344, and MERRF*356 point mutations (Figures 2a-2d called "common" 4977-BP mtDNA deletion (Figure 2e ). MELAS and MERRF cybrids that were homoplasmic for wt-mtDNA and KSS hybrids containing <5 % mut-mtDNA fluoresced brightly. In contrast, MELAS and MERRF cybrids harboring >99% and 100% mut-mtDNA, respectively, and KSS hybrids harboring >99% mut-mtDNA showed very weak fluorescence after incubation in medium containing DHR123. In our initial studies, DHR123 was applied at 5 , 10, or 20 pM for 30, 45, or 60 min at 37°C. In this series, the difference in fluorescence intensity between clonal cells that respired normally and cells that were respiration-deficient was most pronounced when DHR123 was applied at 10 pM for 30 min and was easily observed by visual inspection, using a conventional uv microscope (Figure 2) . Quantitative analysis using a confocal microscope, as described in Materials and Methods, confirmed that the cells with a deficient respiratory chain converted DHR123 to R123 at a significantly lower rate. The cells with impaired oxidative phosphorylation exhibited less than 42% of the fluorescence as the corresponding cells with normal respiratory function. The quantitative data of the MELAS3**3 cells and the MERRF8344 cells are shown in Figure 3 . The rate of growth of 143B cells was studied after incubation in 20 pM DHR123-containing culture medium for 45 min at 37°C to evaluate whether or not there was any apparent cytotoxicity. There was no change in the cell population doubling time for 5 days, compared with untreated control cells. Moreover, all treated cells were morphologically normal, as observed by phase-contrast microscopy (data not shown).
DHR123 staining of uncloned HeLacot x KSS cultures, containing cells with various ratios of deleted and wt-mtDNAs, demonstrated the utility of this method for identifying respiration-deficient single cells or clones in heterogeneous cultures. Essentially two differ- marked, isolated, trypsinized, and propagated individually for 4 weeks for further analysis. In the cell progeny of clones that fluoresced brightly, the percentage of mtDNA with deletions varied significantly, ranging from 18 to 83% (Figure 4) . Although there was some variability in fluorescence intensity in clonal cells that stained brightly, there was no clear correlation between the percentage of mut-mtDNAs and the intensity of fluorescence in brightly stained clones. However, all clones showing barely detectable fluorescence had >99% of mtDNA with deletions (Figures   2e and 4) . One cell colony that initially showed very weak fluorescence showed bright fluorescence when retested after 4 weeks of further cultivation. At that time, Southern blot analysis showed that it possessed 83% deleted mtDNAs (Figure 4) .
Oxygen Utilization
Oxygen consumption measurements performed in cell progeny of several of the isolated clonal HeLacot x KSS hybrids harboring various proportions of deleted mtDNA confirmed that clones with >99% deleted mtDNA and barely detectable fluorescence had impaired oxidative phosphorylation, whereas clonal cells harboring PERCENT MUT-mtDNA Figure 4 . Southern blot analysis of ctonal KSS x HeLacot hybrids that were isolated from a heterogeneous culture, after DHR123 analysis. The relative percentages of mut-mtDNAs were determined as described in Materials and Methods. Cells isolated from brightly fluorescent colonies harbored 18-65% of mut-mtDNAs. whereas cell colonies that stained very faintly harbored >99% mut-mtDNAs. One cell clone initially exhibiting very low fluorescence at the time Of isolation showed bright fluorescence in the cell progeny and 83% mut-mtDNAs after 4 weeks of further cultivation, at the time when the Southern blot was prepared.
5,49,65, or 83% of deleted mtDNAs. and showing bright fluorescence, had normal rates of oxygen consumption (Figure 5 ) . The fluorescence intensities in the clonal cell cultures were quantified by confocal microscopy. As shown in Figure 6 , the fluorescence intensity of the clonal lines with >99% mut-mtDNA was significantly lower than cell lines with lower levels of mut-mtDNAs.
Enzyme Cytochemistry
HeLacot parental cells and selected clonal HeLacot x KSS hybrids harboring, 5 , 50, 78, 83, or >99% mut-mtDNAs were stained cytochemically for COX activity. HeLacot cells and hybrids containing up to 83% showed intense COX staining (Figures 7a-7e ). However, clonal cells containing >99% deleted mtDNAs showed only pale background staining for COX activity (Figure 7f ). This is in agreement with the DHR123 data showing bright fluorescence of the parental HeLacot cells and all clonal hybrids, except for the clone containing cells with >99% deleted mtDNAs. In contrast. cytochemical staining for the mitochondrial enzyme SDH, which is entirely nuclear DNA-encoded, showed strong enzyme activity in the HeLacot parental cells and all hybrids, including the cells harboring >99% mut-mtDNAs (data not shown).
Discussion
The description of large-scale mtDNA deletions in mtDNA by Holt et al. (1988) and of the first mtDNA point mutation by Wallace et al. (1988) marked the beginning of a new era in the field of human mitochondrial genetics. For the past 7 years, a great number of new disease-related mtDNA mutations have been described. Although the pathogenetic mechanisms connecting mtDNA mutations and clinical phenotypes are not completely understood. impaired oxidative phosphorylation certainly plays an important role. The conversion of DHR123 to R123 facilitated the identification of living cells with deficient oxidative phosphorylation. The threshold of wt-mtDNA/mut-mtDNA ratios of cells with defective re- 78 (d). 83 (e), or >99% (1) mut-mtDNAs. Hybrids harboring 583% mut-mtDNAs (b-e) showed strong COX activity, similar to that of HeLacot cells (a), but COX staining was significantly reduced in hybrids >99% mut-mtDNAs (1). Bar = 20 pm. spiratory chain function may vary among different cell types, depending on their specific oxygen demands (see Shoffner and Wallace, 1994; Wallace, 1992 ). This method should be able to distinguish cells above and below this threshold, which is usually very steep.
Oxidative phosphorylation occurs in five respiratory complexes located in the inner mitochondrial membrane. Electron carriers associated with three enzymes catalyze and transfer electrons through the first three complexes to cytochrome c, to complex IV, and finally to oxygen, which is the terminal electron acceptor in this chain. The energy-generating proton gradient created by the flow of electrons can then be utilized to generate ATP from ADP, catalyzed by ATP synthase (for review see .
The range of DHR123 concentrations initially applied was based on the studies of Kinsey et al. (1987) , who synthesized and characterized DHR123 and its iodinated derivatives, studying their uptake, oxidation, and localization in V79 cells.
R123 is a laser dye widely used as a specific fluorescent probe for visualizing mitochondria in living cells. It emits a green or red fluorescence when excited at 485-nm or 546-nm wavelengths, respectively (Johnson et al., 1980) . The molecular basis of R123 interactions with the mitochondrial membrane is not yet fully understood. However, it has been postulated that because of its positive charge at pH 7.0, R123 would be attracted by the negative mitochondrial membrane potential of living cells (Emaus et al., 1986; Johnson et al., 1980) . DHR123, which is nonfluorescent, can be synthesized by reduction of R123 with NaBH4 and readily reconverted to the fluorescent compound after intracellular oxidation (Kinsey et al., 1987) (Figure 1 ). Because of this property, DHR123 has been used as a sensitive indicator of respiratory burst activity in phagocytes and granulocytes (Rothe et al., 1988 (Rothe et al., ,1991 Emmendofier et al., 1990) and was shown to be oxidized by hydrogen peroxide in the presence of an enzyme with peroxidase activity (Henderson and Chappell, 1993; Rothe and Valet, 1990) . Hydrogen peroxide is one of the reactive oxygen intermediates generated by partial reduction of oxygen. During oxidative phosphorylation in mitochondria, the flow of electrons through the respiratory chain leads to the reduction of oxygen and ATP production. Impaired oxidative phosphorylation capacity, as may occur in cells from patients with mitochondrial encephalomyopathies, may also result in a decrease of hydrogen peroxide formation, thus decreasing the conversion rate of DHR123 to R123 inside the mitochondria.
DHR123 application permitted the identification of viable cells or cell clones that are deficient in oxidative phosphorylation, even in heterogeneous cultures. The presence of very low fluorescence in the clonal cells correlated with a high percentage of mut-mtDNAs, decreased rates of oxygen consumption, and decreased levels of cytochrome c oxidase activity. Cells with different percentages of mut-mtDNAs but with normal or near-normal rates of oxygen consumption, situated above the threshold for impairment of oxidative phosphorylation, could not be distinguished by differences in staining intensity. Although there was some variability in the staining intensity of brightly fluorescent cells, this was unrelated to the percentage of mut-mtDNAs. Rather, the noted difference appeared to be caused by differences in cell morphology, as cells that are rounded always appear brighter than more flattened cells, owing to the longer optical path through the cytoplasm.
One clone, of KSS x HeLacot hybrids, which initially exhibited very low fluorescence, showed bright staining with DHR123 after 4 weeks of culture. These cells revealed normal oxygen utilization and were shown to contain 83% deleted mtDNAs (Figure 4) . Such a result is not unexpected, because for KSS x HeLacot hybrids grown under our culture conditions the threshold for reduced oxygen consumption was previously shown to be above 79% of mut-mtDNA (Sancho et al., 1992) . The ratio of mut-mtDNA vs wt-mtDNA can fluctuate in proliferating cells because of mitotic segregation of the mitochondria (Shoubridge, 1995; see Shoffner and Wallace, 19% and Wallace, 1992 for review; Yoneda et al., 1992; Moraes et al., 1989b; Wallace, 1986) . Therefore, cells with mut-mtDNAs near the threshold, which is usually steep, on further growth may convert from respiration-deficient to normal, or vice versa.
The identification of respiration-deficient cell colonies in heterogeneous cultures plated at clonal density often requires examination of a large number of colonies, because the number of colonies with high perecentages of mut-mtDNAs may be very low (Moraes et al., 1989b) . Use of DHR123 to evaluate cells for mitochondrial respiratory chain activity will simplify the identification and isolation of those rare cells with high levels of mut-mcDNA. Because very weakly stained colonies may be missed in microscopic examination, application of a vital nuclear stain, such as Hoechst 33258 dye (see Figure 4) , facilitates the visualization of all colonies independent of their cytoplasmic staining intensity, thus improving the performance of the DHR123 method.
Because DHR123 shows no obvious cytotoxicity, this technique, which can be applied even to single living cells or small cell colonies, has a distinct advantage over more laborious and destructive biochemical and polarographic methods that are traditionally used for evaluating deficient respiratory chain activity in cultured cells. Moreover, it may permit the reevaluation of individual cell clones at selected time intervals, thus allowing an analysis of oxidative phosphorylation under different growth conditions and at sequential stages of cell growth and differentiation. DHR123 could also be employed for estimating the relative numbers of normal and respiration-deficient cells in heterogeneous cultures by flow cytometry. Similarly, phenotypically wild-type or mutant cells can be isolated by fluorescence-activated cell sorting. In addition to the utility of the DER123 method for identlfying and isolating respirationdeficient cultured cells, this technique might also be applicable for evaluating the recovery of mitochondrial function in genetic complementation studies and for in vitro screening of potentially beneficial therapeutic agents.
